Saudi Arabia flu diagnostic and treatment market is projected to grow at a CAGR of 16.69% throughout the forecast period. The market in Saudi Arabia is poised to surge at a decent CAGR owing to the fact that the country is one of the most prominent countries of the Middle East and African region regarding its healthcare. The country spends a significant amount of GDP on healthcare for services and infrastructure of the healthcare both. The healthcare expenditure of the country has been increasing significantly since 2010 which is one of the key factors supporting the market growth in Saudi Arabia during the forecast period. The increasing government spending on healthcare and social development is also anticipated to propel the market growth opportunities for the flu diagnostic and treatment market to surge in Saudi Arabia throughout the forecast period and beyond. This rapid increase in the healthcare sector combined with rising healthcare awareness among people will result in a rise in the demand for various treatments and healthcare services in the country during the forecast period. All these factors collectively contribute to the market growth of the Saudi Arabia flu diagnostic and treatment market during the coming years.
Additionally, the continuous evolution of the healthcare sector in the country as the growing focus of the government towards the privatization of healthcare due to economic diversification and reduce its dependence on the public sector is also anticipated to propel the market growth opportunities during the coming years. Furthermore, the seasonal prevalence of seasonal flu in the country along with the presence of the state-of-art healthcare sector of the country is also projected to positively impact the market growth during the next five years.
Saudi Arabia flu diagnostic and treatment market has been segmented on the basis of the type of flu, offering, age group, and end-user. On the basis of the type of flu, the market has been classified on the basis of type A and type B. Type A flu is anticipated to hold a significant market share as type A is considered to be one of the most common types of flu diagnosed throughout the country. By offering, the market has been segmented into diagnostics and therapeutics. By the age group, the market has been segmented on the basis of 0-14 years, 15-64 years and >=65 years. By the end-user, the segmentation has been done on the basis of hospital laboratory, outpatient clinic, and reference laboratory. The hospital laboratory segment is projected to show decent growth on account of the rising number of patient admissions in hospitals due to seasonal flu outbreak in the country.
Prominent key market players in Saudi Arabia flu diagnostic and treatment market include F. Hoffmann-La Roche Ltd, Meridian Bioscience, and 3M among others. These companies hold a noteworthy share in the market on account of their good brand image and product offerings. Major players in Saudi Arabia flu diagnostic and treatment market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last two years.